Xoft surface brachytherapy
This article was originally published in The Gray Sheet
Executive Summary
FDA grants 510(k) clearance for a skin and surface treatment applicator for use with Xoft's Axxent electronic brachytherapy system, firm says March 4. Axxent's miniaturized X-ray source allows targeted treatment and limits radiation exposure, Xoft adds. The system was initially cleared in 2005 to treat early-stage breast cancer, and gained clearance in 2008 for all radiation therapy indications, with a specific indication for endometrial and rectal cancers